Chronic Insomnia Epidemiology Forecast

DelveInsight’s ‘Chronic Insomnia – Epidemiology Forecast—2030’ report delivers an in-depth understanding of Chronic Insomnia, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2018–2030

Chronic Insomnia Disease Understanding

Insomnia is the most common sleep disorder in the world that carries a huge socio-economic cost. According to the third edition of the Classification of Sleep Disorders (ICSD-3), insomnia is characterized by difficulty in either initiating sleep, maintaining sleep continuity, or poor sleep quality. For chronic insomnia, sleep disturbances occur at least three times a week and have been present for the last 3 months.


Individuals who have difficulty coping with a stressful situation or report being habitual light sleepers have an elevated propensity to develop chronic insomnia. There is a high rate of association between insomnia and psychiatric disorders like depression, anxiety, and post-traumatic stress disorder. Comorbid medical issues like restless legs syndrome, chronic pain, gastroesophageal reflux disease (GERD), respiratory issues, and immobility are associated with the risk of chronic insomnia.


Chronic insomnia represents a more complex condition than acute transient insomnia. Patients with chronic insomnia usually have accompanying daytime impairment of cognition, mood, or performance that impacts the patient and his family and affects friends, coworkers, and caretakers. Insomnia patients are more likely to visit hospitals and physicians, have increased absenteeism, make errors or have accidents at work, and have more fatal road accidentsThere is also an increased risk for depression, anxiety, substance-use, suicide, and possibly immune dysfunction.

Chronic Insomnia Epidemiology

The Chronic Insomnia epidemiology division provides insights about the historical and current patient pool, along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends, along with assumptions undertaken.


Key Findings

The total prevalent cases of Chronic Insomnia patients are increasing in 7MM during the study period, i.e., 2018–2030. The disease epidemiology covered in the report provides historical as well as forecasted Chronic Insomnia symptoms epidemiology segmented as the Prevalence of Insomnia, Diagnosed Prevalent Cases of Chronic Insomnia, Gender-specific cases of Chronic Insomnia, and Age-specific cases of Chronic Insomnia. The report includes the prevalent scenario of Chronic Insomnia symptoms in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.

Country-wise - Chronic Insomnia Epidemiology

The epidemiology segment also provides the Chronic Insomnia epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.


The diagnosed prevalent cases of Chronic Insomnia associated in 7MM countries were 5,585,128 in 2020.

  • As per the estimates, the United States has the largest prevalent population of Chronic Insomnia.
  • Among the EU5 countries, France had the highest prevalent cases of Chronic Insomnia, followed by Germany. On the other hand, Spain had the lowest prevalent cases with 273,947 cases in 2020.

Scope of the Report

  • The Chronic Insomnia report covers a detailed overview explaining its causes, symptoms, and classification, pathophysiology, diagnosis, and treatment patterns.
  • The Chronic Insomnia Epidemiology Report and Model provide an overview of Chronic Insomnia's risk factors and global trends in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
  • The report provides insight into Chronic Insomnia's historical and forecasted patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
  • The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
  • The report assesses the disease risk and burden and highlights the unmet needs of Chronic Insomnia.
  • The report provides the segmentation of the Chronic Insomnia epidemiology by prevalent cases of Insomnia in 7MM.
  • The report provides the Chronic Insomnia epidemiology segmentation by diagnosed prevalent cases of Chronic Insomnia in 7MM.
  • The report provides the Chronic Insomnia epidemiology segmentation by Gender-specific prevalent cases of Chronic Insomnia in 7MM.
  • The report provides the Chronic Insomnia epidemiology segmentation by Age-specific prevalent cases of Chronic Insomnia in 7MM.

Report Highlights

  • 10-year Forecast of Chronic Insomnia epidemiology
  • 7MM Coverage
  • Prevalent Cases of Insomnia
  • Total Diagnosed Prevalent Cases of Chronic Insomnia
  • Prevalent Cases according to segmentation: Gender-specific cases of Chronic Insomnia
  • Prevalent Cases according to segmentation: Age-specific cases of Chronic Insomnia

KOL Views

We interview KOLs, and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

  • What will be the growth opportunities in the 7MM for the patient population about Chronic Insomnia?
  • What are the key findings of the Chronic Insomnia epidemiology across 7MM, and which country will have the highest number of patients during the study period (2018–2030)?
  • What would be the total number of Chronic Insomnia patients across the 7MM during the study period (2018–2030)?
  • Among the EU5 countries, which country will have the highest number of patients during the study period (2018–2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the study period (2018–2030)?
  • What are the disease risk, burden, and unmet needs of Chronic Insomnia?
  • What are the currently available treatments for Chronic Insomnia?

Reasons to buy

The Chronic Insomnia epidemiology report will allow the user to -

  • Develop business strategies by understanding the trends shaping and driving the global Chronic Insomnia market.
  • Quantify patient populations in the global Chronic Insomnia market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Chronic Insomnia therapeutics in each of the markets covered.
  • Understand the magnitude of the Insomnia population by its Total Prevalent cases.
  • Understand the magnitude of the Chronic Insomnia population by its Total Diagnosed Prevalent cases.
  • Understand the magnitude of the Chronic Insomnia population by its Gender-specific cases.
  • Understand the magnitude of the Chronic Insomnia population by its Age-specific cases.
  • The Chronic Insomnia epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
  • The Chronic Insomnia Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over an 10-year forecast period using reputable sources.

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights

2. Report Introduction

3. Chronic Insomnia Market Overview at a Glance

3.1. Market Share (%) Distribution of Chronic Insomnia in 2018

3.2. Market Share (%) Distribution of Chronic Insomnia in 2030

4. Executive Summary of Chronic Insomnia

5. Disease Background and Overview

5.1. Introduction

5.2. Pathophysiology

5.3. Mechanism of Sleep and Insomnia

5.4. Genetics of Insomnia

5.5. Comorbidities of Chronic Insomnia

5.6. Risk Factors

5.7. Diagnosis

5.8. Differential Diagnosis

5.9. Diagnosis Guidelines

5.10. Treatment

6. Epidemiology and Patient Population

6.1. Key Findings

6.2. 7MM Total Diagnosed Prevalent Population of Chronic Insomnia

6.3. Epidemiology of Chronic Insomnia

6.4. The United States

6.4.1. Prevalence of Insomnia in the United States

6.4.2. Diagnosed Prevalent Cases of Chronic Insomnia in the United States

6.4.3. Gender-specific cases of Chronic Insomnia in the United States

6.4.4. Age-specific Cases of Chronic Insomnia in the United States

6.5. EU5

6.5.1. Germany

6.5.1.1. Prevalence of Insomnia in Germany

6.5.1.2. Diagnosed Prevalent Cases of Chronic Insomnia in Germany

6.5.1.3. Gender-specific cases of Chronic Insomnia in Germany

6.5.1.4. Age-specific Cases of Chronic Insomnia in Germany

6.5.2. France

6.5.2.1. Prevalence of Insomnia in France

6.5.2.2. Diagnosed Prevalent Cases of Chronic Insomnia in France

6.5.2.3. Gender-specific cases of Chronic Insomnia in France

6.5.2.4. Age-specific Cases of Chronic Insomnia in France

6.5.3. Italy

6.5.3.1. Prevalence of Insomnia in Italy

6.5.3.2. Diagnosed Prevalent Cases of Chronic Insomnia in Italy

6.5.3.3. Gender-specific cases of Chronic Insomnia in Italy

6.5.3.4. Age-specific Cases of Chronic Insomnia in Italy

6.5.4. Spain

6.5.4.1. Prevalence of Insomnia in Spain

6.5.4.2. Diagnosed Prevalent Cases of Chronic Insomnia in Spain

6.5.4.3. Gender-specific cases of Chronic Insomnia in Spain

6.5.4.4. Age-specific Cases of Chronic Insomnia in Spain

6.5.5. United Kingdom

6.5.5.1. Prevalence of Insomnia in the United Kingdom

6.5.5.2. Diagnosed Prevalent Cases of Chronic Insomnia in the United Kingdom

6.5.5.3. Gender-specific cases of Chronic Insomnia in the United Kingdom

6.5.5.4. Age-specific Cases of Chronic Insomnia in the United Kingdom

6.6. Japan

6.6.1. Prevalence of Insomnia in Japan

6.6.2. Diagnosed Prevalent Cases of Chronic Insomnia in Japan

6.6.3. Gender-specific cases of Chronic Insomnia in Japan

6.6.4. Age-specific Cases of Chronic Insomnia in Japan

7. KOL Views

8. Appendix

8.1. Bibliography

8.2. Report Methodology

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

List of Table

Table 1: Summary of Chronic Insomnia, Market, Epidemiology, and Key Events (2018–2030)

Table 2: Diagnosed Prevalent Population of Chronic Insomnia in 7MM in 000’ (2018–2030)

Table 3: Prevalence of Insomnia in the United States in 000’ (2018–2030)

Table 4: Diagnosed Prevalent Cases of Chronic Insomnia in the United States in 000’ (2018–2030)

Table 5: Gender-specific cases of Chronic Insomnia in the United States in 000’ (2018–2030)

Table 6: Age-specific Cases of Chronic Insomnia in the United States in 000’ (2018–2030)

Table 7: Prevalence of Insomnia in Germany in 000’ (2018–2030)

Table 8: Diagnosed Prevalent Cases of Chronic Insomnia in Germany in 000’ (2018–2030)

Table 9: Gender-specific cases of Chronic Insomnia in Germany in 000’ (2018–2030)

Table 10: Age-specific Cases of Chronic Insomnia in Germany (2018–2030)

Table 11: Prevalence of Insomnia in France in 000’ (2018–2030)

Table 12: Diagnosed Prevalent Cases of Chronic Insomnia in France in 000’ (2018–2030)

Table 13: Gender-specific cases of Chronic Insomnia in France in 000’ (2018–2030)

Table 14: Age-specific Cases of Chronic Insomnia in France (2018–2030)

Table 15: Prevalence of Insomnia in Italy in 000’ (2018–2030)

Table 16: Diagnosed Prevalent Cases of Chronic Insomnia in Italy in 000’ (2018–2030)

Table 17: Gender-specific cases of Chronic Insomnia in Italy (2018–2030)

Table 18: Age-specific Cases of Chronic Insomnia in Italy (2018–2030)

Table 19: Prevalence of Insomnia in Spain in 000’ (2018–2030)

Table 20: Diagnosed Prevalent Cases of Chronic Insomnia in Spain in 000’ (2018–2030)

Table 21: Gender-specific cases of Chronic Insomnia in Spain (2018–2030)

Table 22: Age-specific Cases of Chronic Insomnia in Spain in 000’ (2018–2030)

Table 23: Prevalence of Insomnia in the United Kingdom in 000’ (2018–2030)

Table 24: Diagnosed Prevalent Cases of Chronic Insomnia in the United Kingdom in 000’ (2018–2030)

Table 25: Gender-specific cases of Chronic Insomnia in the United Kingdom (2018–2030)

Table 26: Age-specific Cases of Chronic Insomnia in the United Kingdom (2018–2030)

Table 27: Prevalence of Insomnia in Japan in 000’ (2018–2030)

Table 28: Diagnosed Prevalent Cases of Chronic Insomnia in Japan in 000’ (2018–2030)

Table 29: Gender-specific cases of Chronic Insomnia in Japan (2018–2030)

Table 30: Age-specific Cases of Chronic Insomnia in Japan (2018–2030)

List of Figures

Figure 1: Comorbidities associated with Chronic Insomnia

Figure 2: Diagnosed Prevalent Population of Chronic Insomnia in 7MM in 000’ (2018–2030)

Figure 3: Prevalence of Insomnia in the United States in 000’ (2018–2030)

Figure 4: Diagnosed Prevalent Cases of Chronic Insomnia in the United States in 000’ (2018–2030)

Figure 5: Gender-specific cases of Chronic Insomnia in the United States in 000’ (2018–2030)

Figure 6: Age-specific Cases of Chronic Insomnia in the United States in 000’ (2018–2030)

Figure 7: Prevalence of Insomnia in Germany in 000’ (2018–2030)

Figure 8: Diagnosed Prevalent Cases of Chronic Insomnia in Germany in 000’ (2018–2030)

Figure 9: Gender-specific cases of Chronic Insomnia in Germany in 000’ (2018–2030)

Figure 10: Age-specific Cases of Chronic Insomnia in Germany in 000’ (2018–2030)

Figure 11: Prevalence of Insomnia in France in 000’ (2018–2030)

Figure 12: Diagnosed Prevalent Cases of Chronic Insomnia in France in 000’ (2018–2030)

Figure 13: Gender-specific cases of Chronic Insomnia in France in 000’ (2018–2030)

Figure 14: Age-specific Cases of Chronic Insomnia in France in 000’ (2018–2030)

Figure 15: Prevalence of Insomnia in Italy in 000’ (2018–2030)

Figure 16: Diagnosed Prevalent Cases of Chronic Insomnia in Italy in 000’ (2018–2030)

Figure 17: Gender-specific cases of Chronic Insomnia in Italy in 000’ (2018–2030)

Figure 18: Age-specific Cases of Chronic Insomnia in Italy in 000’ (2018–2030)

Figure 19: Prevalence of Insomnia in Spain in 000’ (2018–2030)

Figure 20: Diagnosed Prevalent Cases of Chronic Insomnia in Spain in 000’ (2018–2030)

Figure 21: Gender-specific cases of Chronic Insomnia in Spain in 000’ (2018–2030)

Figure 22: Age-specific Cases of Chronic Insomnia in Spain in 000’ (2018–2030)

Figure 23: Prevalence of Insomnia in the United Kingdom in 000’ (2018–2030)

Figure 24: Diagnosed Prevalent Cases of Chronic Insomnia in the United Kingdom in 000’ (2018–2030)

Figure 25: Gender-specific cases of Chronic Insomnia in the United Kingdom in 000’ (2018–2030)

Figure 26: Age-specific Cases of Chronic Insomnia in the United Kingdom in 000’ (2018–2030)

Figure 27: Prevalence of Insomnia in Japan in 000’ (2018–2030)

Figure 28: Diagnosed Prevalent Cases of Chronic Insomnia in Japan in 000’ (2018–2030)

Figure 29: Gender-specific cases of Chronic Insomnia in Japan in 000’ (2018–2030)

Figure 30: Age-specific Cases of Chronic Insomnia in Japan in 000’ (2018–2030)

  • Tags:
  • Chronic Insomnia Epidemiology
  • Chronic Insomnia
  • Chronic Insomnia Pipeline
  • Chronic Insomnia Companies
  • Chronic Insomnia prevalent populat...
  • Chronic Insomnia incident populati...
  • Chronic Insomnia patients diagnose...
  • Chronic Insomnia treatment algorit...

Forward to Friend

Need A Quote